Vimarsana
Biggest News Aggregation in the World

Page 10 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

INVO Bioscience, Inc.: INVO Reports First Quarter 2023 Financial Results - Vimarsana News

INVO Bioscience, Inc.: INVO Reports First Quarter 2023 Financial Results

Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., May 15, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company

Arix Bioscience PLC: Portfolio company Ensoma announces closing of Series B Extension - Vimarsana News

Arix Bioscience PLC: Portfolio company Ensoma announces closing of Series B Extension

DJ Portfolio company Ensoma announces closing of Series B Extension Arix Bioscience PLC (ARIX) Portfolio company Ensoma announces closing of Series B Extension 16-May-2023 / 16:36 GMT/BST -----------------------------------------------------------------------------------------------------------------------

LEXARIA BIOSCIENCE CORP. : Entry into a Material Definitive Agreement (form 8-K) - Vimarsana News

LEXARIA BIOSCIENCE CORP. : Entry into a Material Definitive Agreement (form 8-K)

Item 1.0 Entry into a Material Definitive Agreement Lexaria Bioscience Corp. entered into a Master Services Agreement with InClin, Inc. for the purposes of InClin acting as Lexaria's clinical... | May 12, 2023

Arix reports NAV per share of 177 pence at end of April - Vimarsana News

Arix reports NAV per share of 177 pence at end of April

Arix Bioscience PLC - London-based transatlantic venture capital company focused on investing in biotechnology companies that are advancing in life science - Reports its estimated net asset value... | May 12, 2023

Yield10 Bioscience, Inc.: Yield10 Bioscience Announces First Quarter 2023 Financial Results - Vimarsana News

Yield10 Bioscience, Inc.: Yield10 Bioscience Announces First Quarter 2023 Financial Results

Executing commercial strategy for elite Camelina in the biofuels marketMet target for 2023 contracted spring Camelina acresPermitting complete, planting underway for spring seed scale-up and field testing